Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RET | P07949 | 5/20 | 0.44 |
| ▸ | KIT | P10721 | 1/20 | 0.42 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CLK1 | P49759 | 2/20 | 0.40 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30952659 | 0.90 | RET (0.45) | RETLRRK2MAPTSMN1; SMN2GPR119 | |
| SCHEMBL30952662 | 0.90 | RET (0.45) | RETLRRK2MAPTSMN1; SMN2GPR119 | |
| SCHEMBL30952686 | 0.90 | RET (0.45) | RETLRRK2MAPTSMN1; SMN2GPR119 | |
| SCHEMBL24731960 | 0.89 | LCK (0.44) | KITCLK1 | |
| SCHEMBL31218060 | 0.89 | LCK (0.44) | KITCLK1 | |
| SCHEMBL30083171 | 0.89 | RET (0.46) | RETKITLRRK2GPR119 | |
| SCHEMBL30083278 | 0.87 | RET (0.46) | RETMAPTGPR119TP53 | |
| SCHEMBL32688684 | 0.87 | CLK1 (0.40) | KITCLK1 | |
| SCHEMBL30952749 | 0.86 | RET (0.42) | RETLRRK2GPR119TP53 | |
| SCHEMBL32688447 | 0.86 | CLK1 (0.42) | KITCLK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4305022-A1 | ANTI-VIRAL COMPOUNDS | Infex Therapeutics Limited (GB) | 2024-01-17 | — | — | EP | disclosed |
| WO-2022189810-A1 | ANTI-VIRAL COMPOUNDS | Infex Therapeutics Limited (GB) | 2022-09-15 | — | — | WO | disclosed |